Clinical Trial Update: Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy

View source ↗

Summary

This clinical trial update notes the completion of a registry study of patients with chronic hepatitis B receiving nucleotide therapy, sponsored by Gilead Scien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis B | Status: COMPLETED